Mounjaro: What You Should Know About the New Type 2 Diabetes Medicine
Come May 13th, 2022 a new medicine for Type 2 Diabetes known as Mounjaro (Tirzepatide) became available in the market. It is a first-of-its-class…
This study to see how the new medicine IcoSema controls blood sugar levels in people with Type 2 diabetes. IcoSema is a combination of insulin icodec and semaglutide taken in a single injection once a week. When you have type 2 diabetes your blood sugar level is not well controlled, and insulin treatment can be helpful.
If you qualify, you may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.
To take part in the study, participants should be:
CEO and Medical Director
Sub-Investigator
Sub-Investigator
CRC Manager
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Have questions? Call us at (515) 329-6800 or email us at info@iowadiabetes.com.